Obesity, hypertension, and chronic kidney disease
ME Hall, JM do Carmo, AA da Silva… - … journal of nephrology …, 2014 - Taylor & Francis
Obesity is a major risk factor for essential hypertension, diabetes, and other comorbid
conditions that contribute to development of chronic kidney disease. Obesity raises blood …
conditions that contribute to development of chronic kidney disease. Obesity raises blood …
Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept
MP Schlaich, PA Sobotka, H Krum, R Whitbourn… - …, 2009 - Am Heart Assoc
Current therapeutic strategies for these conditions are mainly based on lifestyle
interventions and pharmacological approaches, but the rates of control of blood pressure …
interventions and pharmacological approaches, but the rates of control of blood pressure …
Apparatus for performing a non-continuous circumferential treatment of a body lumen
D Demarais, H Gifford III, M Deem, N Zadno… - US Patent …, 2013 - Google Patents
Methods and apparatus are provided for non-continuous cir cumferential treatment of a body
lumen. Apparatus may be positioned within a body lumen of a patient and may deliver …
lumen. Apparatus may be positioned within a body lumen of a patient and may deliver …
Renal denervation in moderate to severe CKD
Sympathetic activation contributes to the progression of CKD and is associated with adverse
cardiovascular outcomes. Ablation of renal sympathetic nerves reduces sympathetic nerve …
cardiovascular outcomes. Ablation of renal sympathetic nerves reduces sympathetic nerve …
Ultrasound apparatuses for thermally-induced renal neuromodulation
D Demarais, N Zadno, BJ Clark, E Thai… - US Patent …, 2014 - Google Patents
Aug. 16, 2007, noW Pat. No. 7,717,948, Which is a(Continued) continuation of application
No. 11/504,117,? led on continuatlon-m-part of apphcation No. 10/408,665,? led on Apr. 8 …
No. 11/504,117,? led on continuatlon-m-part of apphcation No. 10/408,665,? led on Apr. 8 …
Methods and apparatus for intravasculary-induced neuromodulation
D Demarais, H Gifford III, M Deem, D Sutton… - US Patent …, 2014 - Google Patents
Methods and apparatus are provided for intravascularly-in duced neuromodulation or
denervation. Neuromodulation may be achieved via direct and/or via indirect application of …
denervation. Neuromodulation may be achieved via direct and/or via indirect application of …
Methods for monitoring renal neuromodulation
M Deem, H Gifford III, D Demarais, D Sutton… - US Patent …, 2014 - Google Patents
Methods and apparatus are provided for renal neuromodulation using a pulsed electric field
to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (eg …
to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (eg …
Methods and apparatus for renal neuromodulation
M Deem, D Demarais, D Sutton, H Gifford III… - US Patent …, 2012 - Google Patents
Primary Examiner—Mark W Bockelman Related US Application Data(74) Attorney, Agent, or
Firm—Perkins Coie LLP (63) Continuation-in-part of application No. 1 1/129,765,(57) …
Firm—Perkins Coie LLP (63) Continuation-in-part of application No. 1 1/129,765,(57) …
Sympathetic activation in chronic renal failure
MP Schlaich, F Socratous, S Hennebry… - Journal of the …, 2009 - journals.lww.com
The potential involvement of sympathetic overactivity has been neglected in this population
despite accumulating experimental and clinical evidence suggesting a crucial role of …
despite accumulating experimental and clinical evidence suggesting a crucial role of …
Methods for treating a condition or disease associated with cardio-renal function
D Demarais, H Gifford III, M Deem, D Sutton… - US Patent …, 2012 - Google Patents
Related US Application Data ultrasound, via thermal techniques, etc. Such neuromodula AV
tion may effectuate irreversible electroporation or electrofu (63) Continuation-in-part of …
tion may effectuate irreversible electroporation or electrofu (63) Continuation-in-part of …